Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results
Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Follow us on social media